Shares in Halma plc, the FTSE 100 safety and health technology group, tumbled more than 5% in early trading on Wednesday after the company reported a deceleration in organic revenue growth. The stock fell to around 2,750p, making it one of the worst performers on the blue-chip index, which itself edged lower by 0.3% to 8,280 points.
The group, which specialises in sensors, safety equipment and medical devices, said organic constant currency revenue growth slowed to 6% in the third quarter, down from 8% in the first half of its financial year. Management attributed the slowdown to softer demand in its defence and healthcare divisions, two key end-markets that had previously driven strong performance. The company did not provide a revised full-year forecast but noted that overall trading remained in line with expectations.
Analysts at Shore Capital described the update as 'a touch disappointing' but maintained that Halma's long-term structural growth story remained intact. 'The group's exposure to regulatory-driven safety and environmental markets provides a buffer against cyclical downturns, but the near-term softness in defence and healthcare is clearly weighing on sentiment,' they said in a note.
For UK investors and pension holders, Halma's performance is significant because the company is a staple of many pension funds and income-focused portfolios. Its shares have historically offered steady growth and reliable dividends. Today's decline highlights the vulnerability of even defensive stocks to sector-specific headwinds. The broader FTSE 100 was also under pressure from a stronger pound, which dampened the value of overseas earnings for many exporters.
The healthcare slowdown comes amid ongoing budget constraints in the NHS and other European public health systems, while defence spending cycles can be lumpy. Halma's shares remain up around 8% over the past 12 months, but today's move underscores the market's sensitivity to any hint of a growth deceleration. No investment advice is implied; readers should consult a financial adviser for their personal circumstances.
Source: Halma plc trading update, Shore Capital research note